Maastricht University-ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2024

  1. PsyCog: A computerised mini battery for assessing cognition in psychosis

    Schizophrenia Research: Cognition, Vol. 37

2023

  1. Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions

    Psychiatry Research, Vol. 330

2021

  1. DNA methylation signatures of aggression and closely related constructs: A meta-analysis of epigenome-wide studies across the lifespan

    Molecular Psychiatry, Vol. 26, Núm. 6, pp. 2148-2162

2020

  1. Emotion Recognition and Adverse Childhood Experiences in Individuals at Clinical High Risk of Psychosis

    Schizophrenia bulletin, Vol. 46, Núm. 4, pp. 823-833

  2. Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis

    European Neuropsychopharmacology, Vol. 41, pp. 28-39

2018

  1. Can an experimental white noise task assess psychosis vulnerability in adult healthy controls?

    PLoS ONE, Vol. 13, Núm. 2

2017

  1. Relation between psychotic symptoms, parental care and childhood trauma in severe mental disorders

    Psychiatry Research, Vol. 251, pp. 78-84

2016

  1. Differences in facial emotion recognition between first episode psychosis, borderline personality disorder and healthy controls

    PLoS ONE, Vol. 11, Núm. 7

2015

  1. Data gathering bias: Trait vulnerability to psychotic symptoms?

    PLoS ONE, Vol. 10, Núm. 7

2014

  1. Novel evidence hat attributing affectively salient signal to random noise is associated with psychosis

    PLoS ONE, Vol. 9, Núm. 7

2011

  1. Affectively salient meaning in random noise: A task sensitive to psychosis liability

    Schizophrenia Bulletin, Vol. 37, Núm. 6, pp. 1179-1186

  2. identificando estados de risco para além dos sintomas positivos: Um teste breve que avalia o impacto de disfunções neurocognitivas sobre a interpretação errônea do mundo social resultante de avaliação emocional embotada

    Revista Brasileira de Psiquiatria, Vol. 33, Núm. SUPPL. 2

2010

  1. Neurocognition in bipolar disorders-A closer look at comorbidities and medications

    European Journal of Pharmacology, Vol. 626, Núm. 1, pp. 87-96

2007

  1. Functional impairment in patients with mania: Baseline results of the EMBLEM study

    Bipolar Disorders, Vol. 9, Núm. 1-2, pp. 45-52

2004

  1. The role of age in the development of Schneiderian symptoms in patients with a first psychotic episode

    Acta Psychiatrica Scandinavica, Vol. 109, Núm. 4, pp. 264-268

2003

  1. Age-dependence of Schneiderian psychotic symptoms in bipolar patients

    Schizophrenia Research, Vol. 61, Núm. 2-3, pp. 157-162